The Best of Both Worlds: How TCRs Synergize with the Innate Activity of NK Cells
Time: 11:30 am
day: Day 2
Details:
- Addressing tumor heterogeneity with dual targeting
- Avoiding tumor escape mechanisms
- Delivering an allogeneic off-the-shelf NK cell therapy
